SORT BY

FILTER BY

fastest growing stats

also on other fortune lists

100 Fastest-Growing Companies

78

Jazz Pharmaceuticals

JAZZ

Jazz, which became an Irish company after its merger with Azur Pharma in 2012, has a drug portfolio focused on narcolepsy and hematology.

Looking for leads, investment insights, or competitive intelligence?

Location

Dublin, Ireland

Industry

Pharmaceuticals

Sector

Health Care

Current Streak

1

Years on List

2

CEO

Bruce Cozadd

Revenue and net income for the four quarters ended on or before April 30, 2017. Total return for the period ended June 30, 2017.
Revenue, Net Income
$ millions
Revenue past four quarters ($M)$1,528
Net Income past four quarters ($M)$408
Growth Rates and Ranks
Revenue 3 Yr Growth Rank88
Revenue 3 Yr Annual Growth Rate18%
EPS 3 Yr Growth Rank12
EPS 3 Yr Annual Growth Rate83%
Total Return 3 Yr Rank92
Total Return 3 Yr Annual Rate2%
Beat S&P 500 (9.6%)No
P/E Ratio21
STOCK QUOTE
()0.00 0.00 (0)
  • Previous Close:
  • Market Cap: NaNB
  • Next Earnings Date:
  • High:
  • Low:
  • 52 Week High:
  • 52 Week Low:
  • 52 Week Change %: 0.00
  • P/E Ratio: n/a
  • EPS:
  • Dividend Yield: n/a

News about Jazz Pharmaceuticals

These Troubled Companies Are Reporting Earnings Near Election Day

It'll give them some convenient cover for any bad news.

Read More →
Why drug price controversy is great news for this hedge fund manager

As drug stock prices tumble, one hedge fund manager's loss is another hedge fund manager's gain.

Read More →
Investor AB kills off U.S. venture capital program

Investor Growth Capital will no longer make new U.S. investments.

Read More →